Mom and Pop Sequencing Shop: How Sequencing is Becoming more Affordable
By Eduardo Longoria Since the turn of the 21st century the price of sequencing a single human genome has dropped from the 2.7 billion dollars […]
Biotechs
Putting the Bio in Canadian Biomanufacturing
By Eduardo Longoria “One of the things to remember is Canada no longer has any domestic production capacity for vaccines. We used to have it […]
Spotlight: How Does the Human Gut Microbiota Affect Immune Cell Dynamics?
By Eduardo Longoria An article published recently in the journal Nature reported findings on how the gut microbiota influences the development and maintenance of the mammalian immune […]
Ginkgo Receives $1.1B from the US Government to Fight Pandemics
By Eduardo Longoria Boston-based Ginkgo Bioworks has received a $1.1 billion investment from the US government’s International Development Finance Corp (DFC) for COVID-19 testing and […]
Dewpoint Snags Successful Series B to Target Lesser Known Cellular Compartments
By Eduardo Longoria On September 29th, Dewpoint Therapeutics, the biomolecular condensates company, announced raising US$ 77 million in a Series B round led by ARCH Venture Partners. The round […]
PODCAST – Inovação com Ciência | O cenário inovador das biotechs.
este episódio conversamos com a Isis Eich sobre principais desafios, oportunidades e também um pouco mais sobre o cenário científico. A Isis é Bacharel em […]